CorVel Stock Forecast, Price & News

CorVel (NASDAQ:CRVL) Frequently Asked Questions

How has CorVel's stock price been impacted by Coronavirus (COVID-19)?

CorVel's stock was trading at $64.15 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CRVL shares have increased by 177.0% and is now trading at $177.67.
View which stocks have been most impacted by COVID-19.

When is CorVel's next earnings date?

CorVel is scheduled to release its next quarterly earnings announcement on Tuesday, February 1st 2022.
View our earnings forecast for CorVel.

How can I listen to CorVel's earnings call?

CorVel will be holding an earnings conference call on Tuesday, February 1st at 11:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were CorVel's earnings last quarter?

CorVel Co. (NASDAQ:CRVL) posted its earnings results on Tuesday, November, 2nd. The business services provider reported $0.88 earnings per share for the quarter. The business services provider earned $157.74 million during the quarter. CorVel had a net margin of 9.89% and a trailing twelve-month return on equity of 26.76%.
View CorVel's earnings history.

Who are CorVel's key executives?

CorVel's management team includes the following people:

• Michael G. Combs, President & Chief Executive Officer (LinkedIn Profile)
• Brandon T. O’Brien, Chief Financial Officer (LinkedIn Profile)
• Maxim Shishin, Chief Information Officer (LinkedIn Profile)
• Lori Landon, Vice President-Network Solutions
• Diane J. Blaha, Chief Marketing Officer

What is Michael Combs' approval rating as CorVel's CEO?

30 employees have rated CorVel CEO Michael Combs on Glassdoor.com. Michael Combs has an approval rating of 80% among CorVel's employees.

Who are some of CorVel's key competitors?

Some companies that are related to CorVel include Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), R1 RCM (RCM), AMN Healthcare Services (AMN), Amedisys (AMED), LHC Group (LHCG), MEDNAX (MD), Tivity Health (TVTY) and Cross Country Healthcare (CCRN).
View all of CRVL's competitors.

What other stocks do shareholders of CorVel own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CorVel investors own include Myers Industries (MYE), British American Tobacco (BTI), Canadian Imperial Bank of Commerce (CM), Dominion Energy (D), Consolidated Edison (ED), Gilead Sciences (GILD), Harley-Davidson (HOG), Helmerich & Payne (HP), International Business Machines (IBM) and Meredith (MDP).

What is CorVel's stock symbol?

CorVel trades on the NASDAQ under the ticker symbol "CRVL."

Who are CorVel's major shareholders?

CorVel's stock is owned by a variety of retail and institutional investors. Top institutional investors include Boston Trust Walden Corp (1.50%), Russell Investments Group Ltd. (0.08%), Exchange Traded Concepts LLC (0.05%), State of Alaska Department of Revenue (0.04%) and Wolff Wiese Magana LLC (0.00%). Company insiders that own CorVel stock include Alan Hoops, Brandon O'brien, Corstar Holdings Inc, Diane Blaha, Jean Macino, Jeffrey J Michael, Jennifer Yoss, Maxim Shishin, Michael G Combs, R Judd Jessup, Steven J Hamerslag and V Gordon Clemons.
View institutional ownership trends for CorVel.

Which major investors are selling CorVel stock?

CRVL stock was sold by a variety of institutional investors in the last quarter, including Boston Trust Walden Corp, Russell Investments Group Ltd., and State of Alaska Department of Revenue. Company insiders that have sold CorVel company stock in the last year include Alan Hoops, Brandon O'brien, Corstar Holdings Inc, Diane Blaha, Jean Macino, Jeffrey J Michael, Jennifer Yoss, Maxim Shishin, Michael G Combs, R Judd Jessup, Steven J Hamerslag, and V Gordon Clemons.
View insider buying and selling activity for CorVel or view top insider-selling stocks.

Which major investors are buying CorVel stock?

CRVL stock was acquired by a variety of institutional investors in the last quarter, including Wolff Wiese Magana LLC, and Exchange Traded Concepts LLC.
View insider buying and selling activity for CorVel or or view top insider-buying stocks.

How do I buy shares of CorVel?

Shares of CRVL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CorVel's stock price today?

One share of CRVL stock can currently be purchased for approximately $177.67.

How much money does CorVel make?

CorVel has a market capitalization of $3.15 billion and generates $552.64 million in revenue each year. The business services provider earns $46.36 million in net income (profit) each year or $3.24 on an earnings per share basis.

How many employees does CorVel have?

CorVel employs 3,681 workers across the globe.

What is CorVel's official website?

The official website for CorVel is www.corvel.com.

Where are CorVel's headquarters?

CorVel is headquartered at 1920 Main Street Suite 900, Irvine CA, 92614.

How can I contact CorVel?

CorVel's mailing address is 1920 Main Street Suite 900, Irvine CA, 92614. The business services provider can be reached via phone at (949) 851-1473, via email at [email protected], or via fax at 949-851-1469.